News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Harrow (HROW) was downgraded by Zacks Research from "hold" to "strong sell".

Harrow (HROW) had its price target lowered by Cantor Fitzgerald from $94.00 to $91.00. They now have an "overweight" rating on the stock.

Harrow (HROW) had its price target raised by HC Wainwright from $69.00 to $70.00. They now have a "buy" rating on the stock.

Harrow to Present at Leerink Partner's 2026 Global Healthcare Conference [Yahoo! Finance]

Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference

3/2/2026

04:05 pm

HROW

-28.0%

MISS

11/10/2025

04:05 pm

HROW

13.5%

BEAT

8/11/2025

04:01 pm

HROW

6.1%

BEAT

5/8/2025

04:01 pm

HROW

3.4%

MISS

Form 4 HARROW, INC. For: Feb 27 Filed by: Opaleye Management Inc.

Form 10-K HARROW, INC. For: Dec 31

Form 8-K HARROW, INC. For: Mar 02

Form 4 HARROW, INC. For: Jan 30 Filed by: Sullivan Patrick William

Form 3 HARROW, INC. For: Jan 30 Filed by: Sullivan Patrick William

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}